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Chemokines are a large family (~50 members) of chemoattrac-
tants that bind to cognate chemokine receptors (~25 known).
Leukocytes roll along the vascular endothelium through selectins
interacting with their glycoprotein ligands until they encounter
a chemokine that stops them in their tracks (1, 2). The fact that
chemokines can induce arrest of rolling leukocytes and make them
adhere was discovered in the 1990s (3–6), and the term “arrest
chemokines” was coined in 2003 (7). Many chemokines includ-
ing CXCL1, 2, 8, 9, 10, 12, CCL 3, 5, 11, 19, 21, and CX3CL1
have been shown to activate leukocyte integrins and induce arrest,
but other chemokines may also have this ability and simply have
not been tested in rolling-to-arrest assays. In this Research Topic,
26 authors have contributed 9 articles touching on many of the
known arrest chemokines. This Research Topic is aimed at cover-
ing the structure, expression, and physiological function of arrest
chemokines, the biophysical processes associated with leukocyte
arrest, and the molecular mechanisms of rapid leukocyte integrin
activation responsible for arrest.
Bongrand’s group has pioneered the study of the biomechanics
of cell adhesion for the past 30 years (8). In their contribution to
this Research Topic (9), they discuss the finite time required for
integrin activation, the nanoscale dynamics of the arrest process,
and the contribution of local membrane deformation. They apply
this knowledge of the biomechanics of leukocyte arrest to the
study of the leukocyte arrest defect seen in patients with leukocyte
adhesion deficiency (LAD) type III. In this disorder, the cytoskele-
tal protein kindlin-3 is not expressed and integrin activation is
impaired.
Once rolling leukocytes encounter immobilized or soluble
chemokine, a series of signaling events is triggered that ultimately
results in integrin activation by conformational extension, affin-
ity increase, and clustering. The proximal signaling is clear: the
chemokine binds its G-protein coupled receptor and the Gα sub-
unit dissociates from Gβγ. The distal signaling is also fairly clear:
both talin-1 and kindlin-3 bind to the cytoplasmic domain of the
β chain of the leukocyte integrin responsible for arrest. But what
links the two processes is an area of active investigation. Laudanna
and colleagues focus on the roles Rap1 and RhoA, two of many
small G proteins found in leukocytes (10).
Another signaling paper in this Research Topic focuses on cal-
cium. Intracellular free calcium rises rapidly when a chemokine
binds its receptor, because the dissociated Gβγ subunit of
chemokine receptors can trigger calcium release from intracellu-
lar stores by activating phospholipase C (PLC)β. It has long been
known that arrest is associated with a rise in intracellular free
calcium (11), but it is not known whether this is required and if
so, for which step in the signaling cascade. Scott Simon’s group
has worked on calcium signaling induced by selectin-mediated
leukocyte interactions (12). In their contribution to the Research
Topic, Simon’s group focuses on the calcium rise that occurs after
arrest (13). Their work suggests that elevated intracellular free
calcium is required to induce a migratory phenotype in arrested
neutrophils.
Rolling leukocytes do not always stop, but may instead slow
down considerably. This slower rolling is associated with partial
integrin activation to a state that is known as extended. Talin-1
binding to integrin appears to be sufficient for this. However, for
arrest to occur, integrin extension appears necessary, but not suf-
ficient: a high affinity conformation of integrin is needed. This
last step can be induced by chemokines and requires kindlin-3
(14). Lefort and Ley suggest that talin-1 is required for both inte-
grin extension and high affinity, and kindlin-3 is only required for
inducing the high affinity conformation. A competing hypothesis
is that kindlin-3 may be involved in integrin clustering (15). More
direct evidence in primary leukocytes will be needed to distinguish
between these two competing models.
Chigaev and Sklar have pioneered the use of small fluorescent
peptides to report the activation of integrins. In their contribu-
tion to the Research Topic, they review the insights obtained by
this approach with a focus on the αLβ2 integrin LFA-1 expressed
by all leukocytes and α4β1 integrin expressed by monocytes and
lymphocytes (16).
Among the ~50 chemokines known, only a handful func-
tions as arrest chemokines. One requirement seems to be binding
to the endothelial surface, but not all chemokines that bind to
the endothelial surface induce arrest. Weber’s group was among
the first to describe arrest chemokines (17). In their contri-
bution to this Research Topic, Weber’s group reviews human
chemokines and the therapeutic potential of modulating their
function (18).
Macrophage inhibitory factor (MIF) is not a classical
chemokine, but signals through the chemokine receptor CXCR2
and can activate LFA-1 (19). Bernhagen’s group proposes that MIF
binding to CXCR2 initiates a “motility program” in leukocytes.
Because CXCR2 is one of the most efficient chemokine receptors
triggering arrest, and because it has at least eight known ligands, a
separate review in this Research Topic is focused on this one recep-
tor (20). CXCR2 has been targeted by small allosteric inhibitors,
and some of these show promise in clinical trials, which is the
focus of the contribution by Zarbock’s group (20).
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Some chemokine receptors do not signal through dissociation
of Gα from Gβγ. Initially, these receptors including Duffy anti-
gen receptor for chemokines (DARC) and D6 were called decoy
receptors, because they were thought to sequester chemokines and
prevent them from having effects. In recent years, it has become
clear that these receptors have important functions in transporting
chemokines across endothelial cells. In their contribution to this
Research Topic, Antal Rot’s group focuses on the role of DARC
in this process. In fact, DARC may be a receptor that positions
chemokines correctly on the endothelial surface to fulfill their
arrest function (21).
Although progress on arrest chemokine function over the last
20 years has been remarkable, many aspects still require more
work. It is controversial whether arrest chemokines and their
receptors are monomers,homodimers,or heterodimers. It remains
unknown how calcium signaling may be involved in integrin
activation. We can expect that the exact function of talin-1 and
kindlin-3 in integrin activation will be discovered through novel
structure–function and live cell imaging approaches. An excit-
ing prospect of more research aimed at understanding arrest
chemokines is that their manipulation may have therapeutic
potential in inflammatory diseases.
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